In colon cancer, decreased expression of AIM2 is known to be associated with advanced stages of cancer and tumor progression, while low AIM2 expression is considered to be indicative of poor prognosis (Zhao et al., 2019). This evidence concerns the gene AIM2 and neoplasm.